# A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

> **NCT07100938** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **BeiGene** · enrollment: 49 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** BGB-45035
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07100938
- **Lead sponsor:** BeiGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-21
- **Primary completion:** 2026-10-18
- **Final completion:** 2026-10-18
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07100938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07100938, "A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07100938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*